AB
GBT

Amalgamated Bank’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Amalgamated Bank’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,450
Closed -$712K – 3003
2022
Q3 		$712K Buy
10,450
+579
+6% +$31.9K 0.01% 1249
2022
Q2 		$315K Sell
9,871
-229
-2% -$6.7K ﹤0.01% 1682
2022
Q1 		$350K Sell
10,100
-688
-6% -$20.6K ﹤0.01% 1703
2021
Q4 		$316K Buy
10,788
+142
+1% +$4.4K ﹤0.01% 1796
2021
Q3 		$271K Sell
10,646
-656
-6% -$19.3K ﹤0.01% 1877
2021
Q2 		$396K Buy
11,302
+263
+2% +$10.3K ﹤0.01% 1762
2021
Q1 		$450K Sell
11,039
-959
-8% -$44.1K 0.02% 1044
2020
Q4 		$520K Buy
11,998
+158
+1% +$7.79K 0.02% 945
2020
Q3 		$653K Sell
11,840
-298
-2% -$18.9K 0.03% 691
2020
Q2 		$766K Buy
12,138
+1,783
+17% +$122K 0.04% 557
2020
Q1 		$529K Sell
10,355
-335
-3% -$22.4K 0.01% 881
2019
Q4 		$850K Buy
10,690
+1,035
+11% +$61.3K 0.02% 877
2019
Q3 		$468K Sell
9,655
-117
-1% -$6.1K 0.01% 1073
2019
Q2 		$514K Buy
9,772
+1,804
+23% +$104K 0.01% 1057
2019
Q1 		$422K Buy
7,968
+648
+9% +$31.8K 0.01% 1084
2018
Q4 		$300K Buy
+7,320
New +$274K 0.01% 1174
2018
Q3 		– Sell
-7,624
Closed -$345K – 1660
2018
Q2 		$345K Buy
7,624
+2,420
+47% +$110K 0.01% 1235
2018
Q1 		$251K Buy
+5,204
New +$290K 0.01% 1322

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Amalgamated Bank's GBT Position: Q4 2022 in Review

Amalgamated Bank sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 10,450 shares — an estimated $712K sold.

Amalgamated Bank first reported a position in GBT in Q1 2018 and held it in 18 quarters. The position peaked at $850K in Q4 2019. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Amalgamated Bank reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Amalgamated Bank sold 10,450 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $712K.
  • Amalgamated Bank first reported a position in Global Blood Therapeutics, Inc. in Q1 2018 and held it in 18 quarters.
  • Amalgamated Bank's Global Blood Therapeutics, Inc. position peaked at $850K in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Amalgamated Bank's 13F filing for Q4 2022, filed 10 Feb 2023.